Loading clinical trials...
Loading clinical trials...
Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients at a Tertiary Care Hospital of Karachi.
Conditions
Interventions
Labetalol
Hydralazine
Locations
1
Pakistan
Civil Hospital Karachi
Karachi, Sindh, Pakistan
Start Date
October 1, 2012
Primary Completion Date
September 1, 2014
Completion Date
March 1, 2015
Last Updated
October 26, 2018
NCT06408181
NCT07245056
NCT06821685
NCT04520048
NCT06122220
NCT04783597
Lead Sponsor
Dow University of Health Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions